172 related articles for article (PubMed ID: 12196069)
1. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
Brophy DF
Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the prevention of radiocontrast-induced nephropathy.
Marenzi G; Bartorelli AL
Curr Opin Crit Care; 2004 Dec; 10(6):505-9. PubMed ID: 15616393
[TBL] [Abstract][Full Text] [Related]
3. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
[TBL] [Abstract][Full Text] [Related]
4. Radiocontrast-induced acute renal failure.
Weisbord SD; Palevsky PM
J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
[TBL] [Abstract][Full Text] [Related]
5. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.
Alonso A; Lau J; Jaber BL; Weintraub A; Sarnak MJ
Am J Kidney Dis; 2004 Jan; 43(1):1-9. PubMed ID: 14712421
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine for radiocontrast-induced nephropathy: potential role in the emergency department?
Chong E; Zed PJ
CJEM; 2004 Jul; 6(4):253-8. PubMed ID: 17382001
[TBL] [Abstract][Full Text] [Related]
7. Current trials of interventions to prevent radiocontrast-induced nephropathy.
Asif A; Garces G; Preston RA; Roth D
Am J Ther; 2005; 12(2):127-32. PubMed ID: 15767830
[TBL] [Abstract][Full Text] [Related]
8. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Duong MH; MacKenzie TA; Malenka DJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
[TBL] [Abstract][Full Text] [Related]
10. Prevention of radiocontrast-induced nephropathy.
Asif A; Epstein M
Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
Kelly AM; Dwamena B; Cronin P; Bernstein SJ; Carlos RC
Ann Intern Med; 2008 Feb; 148(4):284-94. PubMed ID: 18283206
[TBL] [Abstract][Full Text] [Related]
12. Fenoldopam in the prevention of contrast media-induced acute renal failure.
Chu VL; Cheng JW
Ann Pharmacother; 2001 Oct; 35(10):1278-82. PubMed ID: 11675860
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.
Isenbarger DW; Kent SM; O'Malley PG
Am J Cardiol; 2003 Dec; 92(12):1454-8. PubMed ID: 14675586
[TBL] [Abstract][Full Text] [Related]
14. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
ACT Investigators
Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
[TBL] [Abstract][Full Text] [Related]
15. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Itoh Y; Yano T; Sendo T; Oishi R
J Pharmacol Sci; 2005 Apr; 97(4):473-88. PubMed ID: 15821342
[TBL] [Abstract][Full Text] [Related]
16. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
17. Acetylcysteine for the prevention of radiocontrast -induced nephropathy.
Tepel M
Minerva Cardioangiol; 2003 Oct; 51(5):525-30. PubMed ID: 14551521
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.
Hoffmann U; Banas B; Fischereder M; Krämer BK
Kidney Blood Press Res; 2004; 27(3):161-6. PubMed ID: 15256811
[TBL] [Abstract][Full Text] [Related]
19. Radiocontrast-induced nephropathy.
Asif A; Preston RA; Roth D
Am J Ther; 2003; 10(2):137-47. PubMed ID: 12629594
[TBL] [Abstract][Full Text] [Related]
20. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.
Misra D; Leibowitz K; Gowda RM; Shapiro M; Khan IA
Clin Cardiol; 2004 Nov; 27(11):607-10. PubMed ID: 15562929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
